Why GENB? Generate Biomedicines, Inc. Analysis, Price & AI Insights | Whystock
GENB
$13.15+0.52 (+4.12%)
Market ClosedLast close May 1
Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States.